They didn’t quite cross paths during Professor Michael Good’s tour of the Uganda Virus Research Institute in 2013, but Aloysious Ssemaganda quickly became aware that a world-renowned researcher in the fight against malaria had been to his place of work.
He discovered that Professor Good, from Griffith University’s Institute for Glycomics, was in Africa searching for a site to conduct malaria vaccine field trials.
His online search also revealed an academic whose unflappable faith in his work had been demonstrated by him being the first person to receive the vaccine he developed.
Download magazine (PDF 5Mb)
View online
More remarkable stories
Soon afterwards, Aloysious emailed Professor Good to inquire about studying a PhD under his supervision. The response was both prompt and encouraging.
In April 2014, having bid an emotional but temporary farewell to his wife and three young children, Aloysious moved to Queensland and immediately thrived in the unique research environment that the Institute for Glycomics